Literature DB >> 1100566

Isometheptene--a non-ergot drug in the treatment of migraine.

S Diamond, J L Medina.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1100566     DOI: 10.1111/j.1526-4610.1975.hed1503211.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  7 in total

Review 1.  Migraine during pregnancy: options for therapy.

Authors:  Anthony W Fox; Merle L Diamond; Egilius L H Spierings
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  The severity model of chronic headache.

Authors:  M J Smith; N M Jensen
Journal:  J Gen Intern Med       Date:  1988 Jul-Aug       Impact factor: 5.128

Review 3.  Fixed drug combinations for the acute treatment of migraine : place in therapy.

Authors:  Elizabeth Loder
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Practical approaches to migraine management.

Authors:  Seymour Diamond; Richard Wenzel
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

5.  The pharmacological management of migraine, part 1: overview and abortive therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-07

6.  Pharmacological analysis of the increases in heart rate and diastolic blood pressure produced by (S)-isometheptene and (R)-isometheptene in pithed rats.

Authors:  Alejandro Labastida-Ramírez; Eloísa Rubio-Beltrán; Oswaldo Hernández-Abreu; Bruce L Daugherty; Antoinette MaassenVanDenBrink; Carlos M Villalón
Journal:  J Headache Pain       Date:  2017-05-04       Impact factor: 7.277

7.  Acute necrotizing eosinophilic myocarditis possibly triggered by an antimigraine drug as an uncommon cause of acute heart failure: a case report.

Authors:  Luís Beck-da-Silva; Alexandre Maulaz; Paulo Schvartzman; Francine Hehn Oliveira; Jonathas Stifft; Claudia Astigarraga; Matias Kronfeld
Journal:  Eur Heart J Case Rep       Date:  2021-08-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.